INHIBITORS
Clinical trials for INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new INHIBITORS trials appear
Sign up with your email to follow new studies for INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hemophilia bleeds: clotting concentrate tested in 30 patients
Disease control Recruiting nowThis study tests a clotting medicine called prothrombin complex concentrate (PCC) to stop bleeding in people with hemophilia A who have developed inhibitors (antibodies that block standard treatment). About 30 participants aged 12 to 65 will receive PCC on-demand during bleeding …
Matched conditions: INHIBITORS
Phase: PHASE4 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New study tracks hemophilia a risks from pregnancy to childhood
Knowledge-focused Recruiting nowThis study follows pregnant women with a severe hemophilia A gene and their babies after birth. The goal is to learn why some mothers have heavy bleeding after delivery and why some children develop antibodies that make hemophilia treatment less effective. By observing 500 mother…
Matched conditions: INHIBITORS
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC